August 19, 2010 – The U.S. Food and Drug Administration (FDA) said last week Boston Scientific has resolved all the manufacturing safety issues cited in a 2006 corporate warning letter.
August 18, 2010 - A new portable system which cools the brain via the nasal cavity may improve survival following cardiac arrest compared with standard care procedures, particularly when cardiopulmonary resuscitation (CPR) and cooling are initiated early.
August 18, 2010 - The U.S. Food and Drug Administration (FDA) today proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension. The FDA said the required post-approval studies that verify the clinical benefit of the drug have not been done.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 18, 2010 - Cardiac computed tomography (CT) was found to be safe, accurate, and cost-effective in low risk patients in a recent scientific statement published by the American Heart Association (AHA), titled “Testing of Low-Risk Patients Presenting to the Emergency Department With Chest Pain.”
August 18, 2010 - Researchers from Mount Sinai School of Medicine have for the first time developed a way to visualize coronary artery plaques vulnerable to rupture using multicolor computed tomography (CT), an innovation that may lead to better and earlier diagnosis of cardiovascular disease. The data are published in the September issue of Radiology.
August 17, 2010 – Certain batches of the St. Jude Medical 6 French Engage Introducer are being recalled because the shaft of some devices may separate from the hub. The company is advising customers to discontinue use of the product.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 17, 2010 – Middle-aged and elderly Swedish women who regularly ate a small amount of chocolate had lower risks of heart failure in a study reported in Circulation: Heart Failure, a journal of the American Heart Association.
The first patient has been enrolled in the Medtronic Dissection Trial, which evaluates the clinical performance of the Valiant Thoracic Stent Graft with the Captivia Delivery System for the treatment of acute, complicated Type B aortic dissection, a serious cardiovascular condition associated with high morbidity and mortality.
August 13, 2010 – A rotary blood pump designed for long-term patient support had another patient surpass four years after receiving the left ventricular assist device (LVAD). Helga Gieseke, 66, who lives in the south of Saxony-Anhalt, Germany is now one of the longest-living heart failure recipients of Terumo Heart’s DuraHeart Left Ventricular Assist System (LVAS).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 12, 2010 - Chicago’s Northwestern Memorial Hospital heart rhythm specialists recently gave a 34-year-old man an implantable cardioverter defibrillator (ICD) that did not require X-ray assistance to install the usual lead wires to the heart.
August 12, 2010 – A 52-year-old male heart failure patient in Krakow, Poland, became the first human to receive the PliCath HF System for an epicardial catheter-based ventricular reconstruction (ECVR). The device is designed to treat heart failure (HF) by reducing the enlarged left ventricle (LV) through an anchoring system that is delivered across the cardiac chambers.
August 11, 2010 – Development of an optical coherence tomography (OCT) imaging system built into an angioplasty balloon is described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics, holds the potential to greatly improve angioplasty.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 11, 2010 – The Bluhm Cardiovascular Institute of Northwestern Memorial Hospital recently implanted a patient with two of the smallest experimental ventricular assist devices (VADs) currently available for study in humans. VADs are designed to assist either the right (RVAD) or left (LVAD) ventricle, or both (BiVAD) at once.
August 11, 2010 – New sizes of the SoloPath TransFemoral Endovascular Access Catheter were recently cleared by the U.S. Food and Drug Administration (FDA). The new sizes provide the potential to treat a larger patient population.
August 11, 2010 – More than 50 percent of cardiologists in a recent survey gave the health reform bill unsatisfactory marks, grading it as a D or an F. Only 1 percent of cardiologists graded it as an A and only 15 percent as a B.